Albireo Announces Closing of $74.8 Million Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares Pharmaceutical Investing
AB Biosciences and Shire Enter Into Agreement for Development and Commercialization of AB Biosciences' PRIM Program Pharmaceutical Investing
Canadian Drug Expert Committee Grants Positive Recommendation for Reimbursement of Galafold Biotech Investing
Alder BioPharmaceuticals, Inc. Announces Offering of $200 Million of Convertible Senior Notes Due 2025 Pharmaceutical Investing
Faron Pharmaceuticals: FDA grants Fast Track Designation to Faron for Traumakine® Pharmaceutical Investing
